The US FDA placed a full clinical hold on two diabetes trials for Biomea’s menin inhibitor after reports of liver toxicity.

The Phase III TEMPO-1 trial enrolled 529 adults, between the ages of 40 and 80, diagnosed with Parkinson’s for less than three years.

Longboard Pharmaceuticals has commenced the Phase III DEEp SEA Study of bexicaserin for treating seizures in Dravet syndrome ...

ProJenX and Unlearn partnered to implement genAI technology for a Phase I trial of prosetin for amyotrophic lateral sclerosis ...

FluMist is a live-attenuated influenza vaccine. Credit: PeopleImages.com – Yuri A via Shutterstock. The US Food and Drug ...

BALVERSA is available as a round, biconvex, film-coated tablet in 3mg, 4mg, or 5mg strengths. BALVERSA is an FGFR kinase inhibitor indicated for treating patients with locally advanced or metastatic ...

The landscape of clinical trials is rapidly evolving with the advent of digital transformation. One of the key innovations revolutionising the industry is electronic consent (econsent, e-Consent), a ...

Sarclisa® is the first approved anti-CD38 therapy along with standard-of-care treatment to treat newly diagnosed multiple myeloma. Sarclisa® (isatuximab-irfc) is indicated for the treatment of ...

An NHS paediatrician sent a WhatsApp message offering children and parents £1,500 to take part in Moderna’s Phase III ...

AbbVie has revealed positive data from a post-hoc analysis of Phase III trials of RINVOQ in treating atopic dermatitis (AD).

Eli Lilly’s EBGLYSS received FDA approval for atopic dermatitis treatment earlier this month. Credit: Katherine Welles / Shutterstock. Eli Lilly and Company has announced new long-term data from the ...

Wegovy is approved for obesity but is also under investigation in a range of other indications. Image credit: Shutterstock / KK Stock. Novo Nordisk’s Wegovy has shown promising benefits in treating a ...